SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-20-108288
Filing Date
2020-09-24
Accepted
2020-09-24 15:47:12
Documents
1
Group Members
DENNISON T. VERUPALISADE CAPITAL ADVISORS, LLCPALISADE CAPITAL MANAGEMENT, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2031745d1_sc13da.htm SC 13D/A 86316
  Complete submission text file 0001104659-20-108288.txt   88089
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Subject) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42755 | Film No.: 201195236
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE BRIDGE PLAZA SUITE 695 FORT LEE NJ 07024
Business Address ONE BRIDGE PLAZA SUITE 695 FORT LEE NJ 07024 201-585-7733
Palisade Concentrated Equity Partnership II, LP (Filed by) CIK: 0001291027 (see all company filings)

IRS No.: 861103899 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A